Recent media reports about health benefits of meditation have led previously naïve populations to seek meditation opportunities in highly variable settings, creating potential for difficult or frustrating experiences and abandonment of further meditation efforts. Unpleasant experiences may exacerbate attrition challenges already present in meditation research, creating negative associations that prevent persistence. This article explores early meditation experiences through the development and preliminary validation of the Early Meditation Hindrances instrument. Items based on the 5 meditation hindrances described in Theravadic texts were generated and statistically reduced by testing for dimensionality. Analyses across Sample 1 (n ϭ 508) and Sample 2 (n ϭ 367) identified 3 consistent factors based on 12 items. The resulting model fits the data well; these factors explained more than half of the variance in intention to persist. Limitations are the retrospective single-survey design and the self-report dependent measure. Consistent results across samples, strong fit of the model with the data, and its relationship with intentions to continue to meditate support strength of the instrument. The Early Meditation Hindrances may be useful for: guiding approaches that reduce attrition in meditation studies, measuring individuals' subjective meditation experience during sessions in which physiological data are gathered, and helping meditation teachers wishing to tailor instruction for individuals and classes. Implications about the setting in which the meditation takes place are examined, and future research needs are described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.